EMBL Australia
EMBL Australia is a government-funded life sciences research network operating the Partner Laboratory Network of early-career research groups across Australian universities, providing training programs and facilitating access to EMBL's bioinformatics and experimental infrastructure for Australian researchers.
- Company typePrivate
- Founded2008
- HeadquartersClayton, Australia
- Headcount51–100
- GTM typeB2B
- OfferingServices
What EMBL Australia does
EMBL Australia is a government-funded life sciences research network, formally launched in March 2010 as Australia's first associate membership of the European Molecular Biology Laboratory (EMBL), a relationship originating in 2008. Headquartered in Clayton, Australia with 51–100 employees, the organization operates primarily through its Partner Laboratory Network — a distributed set of research groups led by early-career scientists hosted at Australian universities including Monash University, Australian National University, University of New South Wales, SAHMRI, QIMR Berghofer, and the Burnet Institute. The network offers up to nine years of funding security to its group leaders, a distinctive model intended to enable high-risk, ambitious research.
The organization's product surface consists of the Partner Laboratory Network itself, the EMBL Australia PhD Course (a two-week residential training program in its tenth year), the AusRISE infrastructure fellowship program, the ECR Network (early career researcher symposiums), and facilitated access for all Australian researchers to EMBL's 40+ bioinformatics/data resources and 20+ experimental services in structural biology, imaging, genomics, proteomics, metabolomics, in vivo gene-editing and chemical biology. EMBL Australia is also a member of the NCRIS Health Group alongside Bioplatforms Australia, the National Imaging Facility, Phenomics Australia, the Population Health Research Network, and Therapeutic Innovation Australia, deepening its integration into Australia's national research infrastructure.
The business model is non-commercial: EMBL Australia is funded primarily through the Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS) for EMBL associate membership, supplemented by competitive research grants from the Australian Research Council, National Health and Medical Research Council, and Medical Research Future Fund, plus philanthropic contributions from organizations such as the Snow Medical Research Foundation and CSL. There are no commercial product sales or service pricing; access is provided through institutional partnerships and grant-funded programs. The organization does not appear to have venture capital or private equity ownership and operates as a network affiliated with EMBL rather than as a wholly-owned subsidiary.
EMBL Australia firmographics
Firmographics- Name
- EMBL Australia
- Legal name
- EMBL Australia
- Website
- https://emblaustralia.org
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- EMBL Australia is a government-funded life sciences research network operating the Partner Laboratory Network of early-career research groups across Australian universities, providing training programs and facilitating access to EMBL's bioinformatics and experimental infrastructure for Australian researchers.
- Ownership category
- akta.pro rank
EMBL Australia industry classification
Industry- Product category
- Life Sciences Research Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Colleges, Universities, and Professional Schools (611310)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Services-Educational Services (8200)
- akta.pro primary industry
- Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)
- akta.pro secondary industry
- Research Administration & Grants Management Support (Pre/Post-Award, Compliance) (EDAEALAO)
Keywords
Where EMBL Australia is headquartered
LocationHeadquarters
- HQ city
- Clayton
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
EMBL Australia business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Others
Revenue model
- Government Funding: Core funding from the Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS) for Australia's associate membership of EMBL.
- Research Grants: Competitive grants from Australian Research Council (ARC), National Health and Medical Research Council (NHMRC), and Medical Research Future Fund (MRFF) supporting network research activities.
- Philanthropic Funding: Funding from organizations such as Snow Medical Research Foundation ($8m fellowship) and CSL Centenary Fellowships ($1.25m each) supporting individual researcher programs.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels8 records
EMBL Australia product offering
Product offeringCore offering
EMBL Australia operates a Partner Laboratory Network of research groups led by early-career researchers at Australian institutions, providing long-term funding and access to world-class scientific infrastructure. It also delivers specialized training programs (PhD Course, AusRISE, ECR Network) and facilitates Australian researchers' access to EMBL's scientific services spanning bioinformatics, structural biology, genomics, proteomics, and chemical biology.
Product overview
EMBL Australia is a life science research network that maximizes Australia's use of EMBL membership. The organization operates primarily through its Partner Laboratory Network—a platform of research groups led by early-career researchers at Australian institutions—supplemented by training programs including the PhD Course, AusRISE infrastructure fellowship program, and ECR Network. The core offering also includes facilitating access to EMBL's scientific services spanning bioinformatics resources, structural biology, imaging, genomics, proteomics, and metabolomics services.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- More than 15 years of delivering top-quality science and state-of-the-art interdisciplinary training
- +2 more outcomes
Companies that use EMBL Australia
Customer profileNamed customers9 records
Segments4 records
Ideal customer profiles3 records
EMBL Australia technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
EMBL Australia partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered flagship, core, major and minor.
- European Molecular Biology Laboratory (EMBL)flagshipAustralia's associate membership of EMBL (since 2008) is the foundational relationship. This intergovernmental organization's 28 member states provide access to EMBL's world-class scientific technologies, infrastructure and data resources for all Australian researchers. The partnership includes the Partner Laboratory Network model and access to EMBL sites across Europe.
- NCRIS Health GroupcoreEMBL Australia signed a Memorandum of Understanding to join the NCRIS Health Group, strengthening Australian collaborative health research. The group includes Bioplatforms Australia, National Imaging Facility, Phenomics Australia, Population Health Research Network, and Therapeutic Innovation Australia.
- Bioplatforms AustraliacoreNCRIS-funded partner providing genomics and bioinformatics infrastructure support. Collaborated on events such as the AI in life sciences workshop featuring EMBL-EBI Director.
- ARC Centre of Excellence for the Mathematical Analysis of Cellular SystemsmajorProfessor Eduardo Eyras and Dr Richard Morris serve as chief investigators in this ARC Centre of Excellence, applying advanced mathematics to model biological processes.
- ARC Centre of Excellence for Innovations in Peptide and Protein SciencemajorProfessor Max Cryle leads the Victorian node of this $35 million ARC Centre, overseeing training and mentoring programs.
- Monash UniversitycoreMajor partner hosting the Australian Regenerative Medicine Institute (ARMI) node, multiple group leaders, and training programs including mRNA training partnership for PhD students.
- Australian National UniversitycoreHost institution for the Eyras Group and Department of Genome Sciences, part of the Partner Laboratory Network.
- University of New South WalescoreHost institution for EMBL Australia Node of Single Molecule Science and multiple group leaders.
- South Australian Health and Medical Research InstitutecoreHost institution for South Australian node and South Australian Genomics Centre, founded in partnership with multiple SA universities.
- Monash mRNA Workforce Training CentreminorPartnership delivering intensive mRNA Design and Optimisation training program for EMBL Australia PhD students.
- QIMR Berghofer Medical Research InstitutecoreOriginal host institution for Dr Michelle Boyle's malaria research program before relocation to Burnet Institute.
- Burnet InstitutecoreCurrent host institution for Dr Michelle Boyle's malaria research and Disease Elimination Program.
- South Australian immmunoGENomics Cancer Institute (SAiGENCI)coreHost institution for Dr Qi Zhang as first EMBL Australia Group Leader based there, established 2023.
Scale indicators7 records
Recent moves9 records
Expansion highlights6 records
EMBL Australia competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
EMBL Australia social profiles
Digital presenceEMBL Australia financial estimates
Financial estimateRevenue estimate
Valuation estimate
EMBL Australia leadership team
Management profileNumber of profiles
Profiles5 records
EMBL Australia funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EMBL Australia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EMBL Australia
What does EMBL Australia do?
EMBL Australia operates a Partner Laboratory Network of research groups led by early-career researchers at Australian institutions, providing long-term funding and access to world-class scientific infrastructure. It also delivers specialized training programs (PhD Course, AusRISE, ECR Network) and facilitates Australian researchers' access to EMBL's scientific services spanning bioinformatics, structural biology, genomics, proteomics, and chemical biology.
Is EMBL Australia a public or private company?
EMBL Australia is a private company. It is classified as state government owned and is currently operating.
When was EMBL Australia founded?
EMBL Australia was founded in 2008. It employs 51 to 100 people.
Where is EMBL Australia based?
EMBL Australia is headquartered in Clayton, Australia, in the Oceania region.
How does EMBL Australia make money?
Three revenue lines are on record. Government Funding is the primary driver. The others are research Grants and philanthropic Funding.
Does EMBL Australia have an API?
No public API is recorded for EMBL Australia.
What industry is EMBL Australia in?
EMBL Australia's product category is Life Sciences Research Services. Its primary akta.pro industry code is EDAHAGAI, Biomedical Sciences & Medical Research Institutes (University-Based), with a secondary code of EDAEALAO, Research Administration & Grants Management Support (Pre/Post-Award, Compliance). Its NAICS code is 54171 and its SIC code is 8731.